Clinical Trial Update: Novel Biomarkers Related Xuebijing Injection Improves Sepsis

View source ↗

Summary

A clinical trial update shows exploration of novel biomarkers related to Xuebijing Injection for sepsis, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Xuebijing Injection

Snippet

Sponsor: Southeast University, China | Conditions: Sepsis | Status: NOT_YET_RECRUITING